: GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses #FinanceUSA #StockMarketNEWS GlaxoSmithKline PLC announced Thursday an agreement to supply the Government
@stockMarketNEWS Sun 09 Jan, 2022
GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses #FinanceUSA #StockMarketNEWS
GlaxoSmithKline PLC announced Thursday an agreement to supply the Government of Canada with 20,000 doses of Sotrovimab, the COVID-19 monoclonal antibody therapy the company developed with Vir Biotechnology Inc. . The agreement follows Canada's initial order of 10,000 doses of Sotrovimab announced in October, which included options for additional purchases. Sotrovimab was authorized for injection by Health Canada in July 2021 to treat mild to moderate COVID-19 in adults and adolescents 12 years old and older who are at high risk for hospitalization and death. Glaxo's stock slipped 0.1% in afternoon trading and Vir shares eased 0.1%, while the S&P 500 gained 0.1%.
Munafa USA Munafa India Munafa NSE
More posts by @stockMarketNEWS
: Canadian cannabis company CannTrust developing 'orderly wind-down plan' after debt default #FinanceUSA #StockMarketNEWS CannTrust Holdings Inc. said Thursday it's developing an "orderly wind-down
@stockMarketNEWS Sun 09 Jan, 2022
: : T-Mobile stock slips following quarterly customer results #FinanceUSA #StockMarketNEWS T-Mobile Inc. TMUS shares slipped in the extended session Thursday after the telecom company reported it posted
@stockMarketNEWS Sun 09 Jan, 2022
0 Comments
Sorted by latest first Latest Oldest Best